M. Brownlee
- Clinical Biochemistry top 0.02%
- Advanced Glycation End Products research 25
-
- Natural Antidiabetic Agents Studies 8
- Ophthalmology top 1%
- Retinal Diseases and Treatments 7
- Neurology top 1%
- Neurological Disorders and Treatments 7
- Nephrology top 1%
-
- Diabetes and associated disorders 7
-
- Pancreatic function and diabetes 7
-
- Glycosylation and Glycoproteins Research 5
-
- Nitric Oxide and Endothelin Effects 3
M. Brownlee
50 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Clinical Biochemistry 3.0k
- Endocrinology, Diabetes and Metabolism 1.9k
- Ophthalmology 654
- Neurology 529
- Nephrology 427
Countries citing papers authored by M. Brownlee
This map shows the geographic impact of M. Brownlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Brownlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Brownlee more than expected).
Fields of papers citing papers by M. Brownlee
This network shows the impact of papers produced by M. Brownlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Brownlee. The network helps show where M. Brownlee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Brownlee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 20 | |
| 2 | 2011 | 129 | |
| 3 | 2010 | 144 | |
| 4 | 2008 | 58 | |
| 5 | 2006 | 80 | |
| 6 | 2005 | 93 | |
| 7 | 2004 | 179 | |
| 8 | 1999 | 79 | |
| 9 | 1999 | 165 | |
| 10 | 1997 | 39 | |
| 11 | 1997 | 10 | |
| 12 | 1996 | 215 | |
| 13 | 1995 | 32 | |
| 14 | 1995 | 62 | |
| 15 | The pathological implications of protein glycation. | 1995 | 132 |
| 16 | 1994 | 99 | |
| 17 | 1993 | 24 | |
| 18 | 1991 | 85 | |
| 19 | 1987 | 66 | |
| 20 | A glucose-controlled insulin-delivery system: Semisynthetic insulin bound to lectin | 1980 | 38 |
About M. Brownlee
M. Brownlee is a scholar working on Clinical Biochemistry, Neurology and Ophthalmology, having authored 50 papers that have together received 6.2k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (25 papers), Natural Antidiabetic Agents Studies (8 papers), Retinal Diseases and Treatments (7 papers), Diabetes and associated disorders (7 papers), Neurological Disorders and Treatments (7 papers), Pancreatic function and diabetes (7 papers), Glycosylation and Glycoproteins Research (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). The work is most often cited by research in Clinical Biochemistry (3.0k citations), Endocrinology, Diabetes and Metabolism (1.9k citations) and Ophthalmology (654 citations). M. Brownlee has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Anthony Cerami, Helen Vlassara, Diane Edelstein, Peter Ulrich, Ida Giardino, Qida Ju, C Sui, Stefanie Dimmeler, K. Federlin and Hans‐Peter Hammes. Their work appears in journals such as Diabetologia, Diabetes, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.